慢性肝炎与肝硬化有什么区别？
What distinction do chronic hepatitis and liver cirrhosis have?
乙型肝炎病毒(造成肝炎，慢性肝炎可导致肝癌)。
Hepatitis B virus (causes hepatitis and chronic cases may lead to cancer of the liver).
目的：观察丹参对慢性肝炎纤维化指标的疗效。
Objective: To observe the therapeutic effect on the indexes of chronic hepatitis fibrosis with Dan-shen.
结论：硫普罗宁是治疗慢性肝炎安全有效的药物。
Conclusion: Tiopronin is save and effective in patients with chronic hepatitis.
目的探讨慢性肝炎临床病理分级分期的诊断指标。
Objective To investigate the diagnosis of clinical and pathological grading and staging of chronic hepatitis B (CHB).
结果表明，慢性肝炎与发硒含量降低有一定关系。
The results show that chronic hepatitis has certain relations with the reducing of the hair selenium content.
目的评价易善复治疗慢性肝炎的有效性与安全性。
Objective To evaluate the efficacy and safety of Polyunsaturated phosphatidylcholine (PPC) for chronic hepatitis.
目的探讨慢性肝炎肝纤维化血清学指标与病理之间的关系。
Purpose To appraise the relationships between serum markers of liver fibrosis and pathological changes in chronic hepatitis.
目的阐明慢性肝炎纤维化程度与门脉血流动力学的相关性。
Objective To explore the relationship between portal vein hemodynamics and the severity of fibrosis in patients with chronic hepatitis.
结论中药离子透入对慢性肝炎伴脾肿大的治疗有显著效果。
Conclusion TCM iontophoresis has obvious therapeutic effect on chronic hepatitis with splenomegaly.
临床类型以慢性肝炎、重型肝炎多见，其中慢性肝炎最多；
The chronic hepatitis and severe hepatitis were more in the clinical type, and the chronic hepatitis was the most.
在移植后慢性肝炎的初次诊断时间中位数为15.25个月。
CH was first diagnosed at a median of 15.25 months after transplantation.
降低和增高程度的顺序是肝硬化、慢性肝炎、急性黄疸性肝炎。
In the order of the reduced and elevated level are cirrhosis, 'chronic hepatitis,' acute jaundice hepatitis.
丙肝病毒可以导致慢性肝炎，肝硬化，肝细胞肝癌或原发性肝癌。
HCV infection can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) or primary liver cancer.
探讨慢性肝炎及肝细胞肝癌组织中CD 86表达与临床的关系。
To investigate the expression and clinical significance of CD86 in chronic hepatitis and hepatoma.
目的：比较急、慢性肝炎患者心理状况及其与肝功能之间的关系。
Objective: To compare the mental healthy status of the patients with acute or chronic hepatitis and its relation with liver function.
慢性肝炎患者肝脏病理分级分期与血清肝纤维化指标存在相关性。
There was a positive correlation between the pathology grade and stage with hepatic fibrosis indexes.
慢性肝炎通过活动程度(坏死与炎症)分级，通过纤维化程度分期。
The extent of chronic hepatitis can be graded by the degree of activity (necrosis and inflammation) and staged by the degree of fibrosis.
血清CHE除慢性肝炎外，其他各类肝病的阳性率都在90%左右。
The positive rates of CHE were about 90% in all groups of liver diseases except the group of chronic hepatitis.
目的探讨肝功能正常的慢性肝炎病毒携带者的肝组织病理分级和分期。
Objective To study liver pathology in chronic hepatitis B virus (HBV) carriers with normal liver function.
结论：温阳祛瘀化痰法治疗慢性肝炎、肝硬化轻度黄疸疗效确切，安全可靠。
Conclusion: WYQYHT decoction has confirmatory effect on low grade jaundice due to chronic hepatitis and hepatocirrhosis, and it is safe.
目的考察复方五仁醇胶囊对损伤肝细胞的保护作用及对慢性肝炎的治疗效果。
Objective to investigate the protective effect of the Compound Wurenchun Capsula (CWC) on injured hepatocyte patients with chronic hepatitis.
结论肝硬化、重度慢性肝炎患者是医院感染的高发人群，预后差，死亡率高。
The patients with cirrhosis or severe chronic hepatitis have higher nosocomial infectious probability. They have unfavourable prognosis and higher mortality.
血清GPDA对慢性肝炎的诊断及病情估计有一定的意义，但敏感性不如ALT。
There is some significance of serum GPDA for diagnosis of chronic hepatitis, but the sensitivity of GPDA is lower them that of ALT.
结论慢性肝炎临床病理量化诊断指标简单易行，便于临床医师掌握，具有较好的实用性。
Conclusions Quantificational clinical pathological diagnosis indexes were simple and accessible for physician to grasp. It was of great value to diagnose hepatitis b.
结果表明慢性肝炎和肝硬化血清prl水平均高于正常，其中尤以肝性脑病患者最为显著。
The results showed that the serum PRL levels IP both chronic hepatitis and hepatocirrhosis were higher than that in normal person, especially markedly higher in hepatic encephalopathy.
目的应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝，进一步评价其安全性和疗效。
Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver.
目的应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝，进一步评价其安全性和疗效。
Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver.
应用推荐